The Latest in MPN Research with Dr. Ruben Mesa
Read Transcript
Download Transcript 
Share This Video
Take Our SurveyDr. Ruben Mesa, deputy director of the Mayo Clinic Cancer Center, talks about why this is an exciting time in research for patients living with myeloproliferative neoplasms (MPNs), how far we’ve come with our understanding of the biology of the disease and where we are with better pain symptom assessment tools. Dr. Mesa also talks about the upcoming Midwest MPN Patient Symposium put on by the MPN Research Foundation and how events like these help build community among patients facing the same challenges. Discussions will include how genetic testing is answering questions about where the disease comes from, why it progresses, when to consider bone marrow transplant and maintaining quality of life.
Patient Power and the MPN Research Foundation have partnered to achieve greater impact in providing educational information and empowerment to patients and people who care about them.
The primary mission of the MPN Research Foundation is to stimulate original research in pursuit of new treatments—and eventually a cure—for polycythemia vera, essential thrombocythemia and myelofibrosis, known collectively as myeloproliferative neoplasm’s (MPN).
Get Email Updates:
Privacy Policy
Experts & Guests
|
Ruben Mesa, M.D.
Deputy Director, Mayo Clinic Cancer Center, Mayo Clinic
Dr. Ruben Mesa is board certified in internal medicine, hematology and medical oncology and is director of the Acute and Chronic Leukemias Program in the Division of Hematology-Oncology at Mayo Clinic in Arizona. Dr. Mesa is also a professor of medicine. The Chicago-area native's primary field of interest is hematology with special interests in both acute and chronic leukemias —...
more >
|
|
|
